Neuroscience research has dramatically advanced our understanding of mild cognitive impairment's mechanisms, informing better treatments and reducing stigma.
Key Brain Structures in Mild Cognitive Impairment
Modern neuroimaging has identified consistent patterns in mild cognitive impairment:
- Amygdala: Threat processing center shows altered activation patterns in mild cognitive impairment
- Prefrontal Cortex: Top-down emotional regulation — often underactive in mild cognitive impairment
- Anterior Cingulate Cortex: Conflict monitoring and pain processing — implicated in mild cognitive impairment
- Hippocampus: Memory and context; chronic stress in mild cognitive impairment can affect its volume
- Default Mode Network: Rumination and self-referential thinking network — often overactive in mild cognitive impairment
Neurochemistry of Mild Cognitive Impairment
While the 'chemical imbalance' model is oversimplified, neurotransmitter systems play real roles in mild cognitive impairment:
- Serotonin regulates mood, appetite, and sleep — all affected in mild cognitive impairment
- Dopamine drives motivation and reward — disrupted in many mild cognitive impairment presentations
- GABA and glutamate modulate excitation/inhibition balance relevant to mild cognitive impairment
What Neuroscience Means for Mild Cognitive Impairment Treatment
Neuroscience validates that mild cognitive impairment is a brain condition, not a character failing. It points toward treatments that target specific mechanisms — and shows that both therapy and medication physically change the brain.